Skip to content
value.today

Amedica Corp.

Total raised
$52 M
5 rounds on record
Latest round
$6 M
Jun 2014
First round on record
Feb 2010
Today
Went public
See the company page

Amedica Corp. is listed today as SiNtx Technologies, Inc.: market value, financials and filings are on its company page.

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Amedica Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2014$6 MNo. 5$2 to $10 million

Amedica Corp.: Raise no. 5, Jun 2014

Investors in this round

1 investor had bought by the notice of Jul 15, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Amedica Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $9 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bryan J McEntire · Executive Officer
  • Christopher R. Whitfield · Executive Officer
  • Eric K Olson · Executive Officer, Director
  • James P Abraham · Executive Officer, Director
  • Jay M Moyes · Executive Officer, Director
  • Kevin J Ontiveros · Executive Officer
  • Kevin P Davis · Executive Officer
  • Vytas J Rupinskas · Executive Officer, Director
  • B. Sonny M Bal · Director
  • David W Treutzel · Director
  • Jeffrey S White · Director
  • Max E Link · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin Ontiveros, Chief Legal Officer and Chief Compliance Officer. Source: SEC Form D, newest notice filed Jul 15, 2014. Read the notice at the SEC.

debt, optionsSEC
Aug 2013$9 MNo. 4$2 to $10 million

Amedica Corp.: Raise no. 4, Aug 2013

Investors in this round

45 investors had bought by the notice of Oct 4, 2013: 45 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Amedica Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$9 M of $10 M offered; $1 M still to sell
Smallest investment taken
$20,000
What was sold
equity, options or other rights to buy securities, other: The Company sold units consisting of preferred stock and warrants to purchase common stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$480,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bryan J. McEntire · Executive Officer
  • Eric K. Olson · Executive Officer, Director
  • Karl M. Farnsworth · Executive Officer
  • Kevin J. Davis · Executive Officer
  • Kevin J. Ontiveros · Executive Officer
  • David M. Truetzel · Director
  • Jay M. Moyes · Director
  • Max K. Link · Director
  • Sonny K. Bal · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Kevin P. Murphy (CRD 1680861) · broker-dealer TGP Securities, Inc. (CRD 159008) · New York, New YorkSold in CA, FL, NJ, NY, TX, VA

Remarks in the notice

  • On fees: “TGP Securities, Inc. received $480,000 and warrants to purchase 240,000 shares of common stock, exercisable for $2.20 per share, expiring in five years.”
  • On the amounts: “The Company sold units consisting of shares of convertible preferred stock and warrants to purchase common stock.”

Signed by Kevin Ontiveros, Chief Legal Officer & Chief Compliance Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 4, 2013. Read the notice at the SEC.

equity, optionsSEC
Feb 2013$3 MNo. 3$2 to $10 million

Amedica Corp.: Raise no. 3, Feb 2013

Investors in this round

34 investors had bought by the notice of Apr 12, 2013: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Amedica Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, other: In connection with the cash exercise of already outstanding common warrants, the issuer issued replacement warrants.
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bryan J. McEntire · Executive Officer
  • Eric K. Olson · Executive Officer, Director
  • F. Karl J. Farnsworth · Executive Officer
  • Kevin J. Davis · Executive Officer
  • Kevin J. Ontiveros · Executive Officer
  • David M. Truetzel · Director
  • George M. Singer · Director
  • Gregg R. Honigblum · Director
  • Jay M. Moyes · Director
  • Max K. Link · Director
  • Rohit M. Patel · Director
  • Sonny K. Bal · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin Ontiveros, Chief Legal Officer & Chief Compliance Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 12, 2013. Read the notice at the SEC.

equity, optionsSEC
Mar 2011$22 MNo. 2$10 to $50 million

Amedica Corp.: Raise no. 2, Mar 2011

Investors in this round

69 investors had bought by the notice of Jul 15, 2011: 69 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Amedica Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$22 M of $30 M offered; $8 M still to sell
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$938,187
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ben E Shappley · Executive Officer, Director
  • Max E Link, Ph.D. · Executive Officer, Director
  • Reyn E Gallacher · Executive Officer
  • David E Truetzel · Director
  • Gregg R Honigblum · Director
  • Rohit H Patel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Creation Capital, LLC (CRD 113912) · broker-dealer Creation Capital, LLC · Austin, TexasSold in AZ, CA, CO, CT, FL, GA, IL, LA, MA, MO, NC, NJ, NV, NY, OK, PA, TX, UT

Remarks in the notice

  • On fees: “Creation Capital, LLC, Placement Agent”

Signed by Reyn E. Gallacher, VP of Finance, CFO, COO and Asst. Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jul 15, 2011. Read the notice at the SEC.

debt, optionsSEC
Feb 2010$11 MNo. 1$10 to $50 million

Amedica Corp.: Raise no. 1, Feb 2010

Investors in this round

96 investors had bought by the notice of Mar 15, 2010: 96 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Amedica Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$11 M of $30 M offered; $19 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,400,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ashok R. Khandkar · Executive Officer, Director
  • Ben R. Shappley · Executive Officer, Director
  • Bryan McEntire · Executive Officer
  • Jonathan Stupka · Executive Officer
  • Ken Eakin · Executive Officer
  • Max Link · Executive Officer, Director
  • Reyn Gallacher · Executive Officer
  • Gregg Honigblum · Director
  • Rohit R. Patel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Creation Capital (CRD 113912) · Melville, NySold in no state named

Remarks in the notice

  • On fees: “The Placement Agent also wil receive five-year warrants exercisable for up to 1,200,000 Series E Preferred Stock at $2.20 per share.”
  • On the amounts: “Investors who buy Series E = to 25% or more of amount rec?d when we issued our current Preferred may convert their shares to alternate Preferred. Current Preferred & alternate series are identical. Except alternate Preferred converts to 50% more of Common”

Signed by Reyn E. Gallacher, VP of Finance and CFO. Source: SEC Form D, newest notice filed Mar 15, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company SiNtx Technologies, Inc., its revenue in fiscal 2025 came from these product and service lines: Grant and Contract $290,000 (28%).

    Annual report (SEC XBRL) · Dec 2025

  • Amedica Corp. chose not to state its revenue in its newest notice of a funding round (Jul 2014).

    SEC Form D · Jul 2014

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2014

Products and services#

No products or services of Amedica Corp. are on record.

Investors#

4 named in official filings. Open an investor to see everything it has backed.

Investors in Amedica Corp.
InvestorKindAmountRoundRoleSource
Bhajanjit BalPersonnot statednot statedHeld Series B-1, C, D-1, E and F preferred stock, director (Form 3, 2014)SEC Form 3
David W. TruetzelPersonnot statednot statedHeld Series E preferred stock, director (Form 3, 2014)SEC Form 3
Jay M. MoyesPersonnot statednot statedHeld Series A preferred stock, director (Form 3, 2014)SEC Form 3
Max LinkPersonnot statednot statedHeld Series A-1, C, D, E and F preferred stock, director (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 96 investors.

Largest shareholders today

Institutions holding SiNtx Technologies, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Amedica Corp.
NameRoleNamed in
Bryan J McEntireExecutive officerJul 2014
Christopher R. WhitfieldExecutive officerJul 2014
Eric K OlsonExecutive officerJul 2014
James P AbrahamExecutive officerJul 2014
Jay M MoyesExecutive officerJul 2014
Kevin J OntiverosExecutive officerJul 2014
Kevin P DavisExecutive officerJul 2014
Vytas J RupinskasExecutive officerJul 2014
Bryan J. McEntireExecutive officerOct 2013
Eric K. OlsonExecutive officerOct 2013
Karl M. FarnsworthExecutive officerOct 2013
Kevin J. DavisExecutive officerOct 2013
Kevin J. OntiverosExecutive officerOct 2013
F. Karl J. FarnsworthExecutive officerApr 2013
Ben E ShappleyExecutive officerJul 2011
Max E Link, Ph.D.Executive officerJul 2011
Reyn E GallacherExecutive officerJul 2011
Ashok R. KhandkarExecutive officerMar 2010
Ben R. ShappleyExecutive officerMar 2010
Bryan McEntireExecutive officerMar 2010
Jonathan StupkaExecutive officerMar 2010
Ken EakinExecutive officerMar 2010
Max LinkExecutive officerMar 2010
Reyn GallacherExecutive officerMar 2010
B. Sonny M BalDirectorJul 2014
David W TreutzelDirectorJul 2014
Eric K OlsonDirectorJul 2014
James P AbrahamDirectorJul 2014
Jay M MoyesDirectorJul 2014
Jeffrey S WhiteDirectorJul 2014
Max E LinkDirectorJul 2014
Vytas J RupinskasDirectorJul 2014
David M. TruetzelDirectorOct 2013
Eric K. OlsonDirectorOct 2013
Jay M. MoyesDirectorOct 2013
Max K. LinkDirectorOct 2013
Sonny K. BalDirectorOct 2013
George M. SingerDirectorSep 2013
Gregg R. HonigblumDirectorSep 2013
Rohit M. PatelDirectorSep 2013

Went public since 2014. Its SEC number is that of a company listed on a stock exchange.